385 related articles for article (PubMed ID: 26097867)
41. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
[TBL] [Abstract][Full Text] [Related]
42. The importance of codon context for understanding the Ig-like somatic hypermutation strand-biased patterns in TP53 mutations in breast cancer.
Lindley RA
Cancer Genet; 2013 Jun; 206(6):222-6. PubMed ID: 23880211
[TBL] [Abstract][Full Text] [Related]
43. Evolvability of cancer-associated genes under APOBEC3A/B selection.
Song JH; Dávalos LM; MacCarthy T; Damaghi M
bioRxiv; 2023 Dec; ():. PubMed ID: 38106028
[TBL] [Abstract][Full Text] [Related]
44. Breaking bad: The mutagenic effect of DNA repair.
Chen J; Furano AV
DNA Repair (Amst); 2015 Aug; 32():43-51. PubMed ID: 26073774
[TBL] [Abstract][Full Text] [Related]
45. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.
Bhagwat AS; Hao W; Townes JP; Lee H; Tang H; Foster PL
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2176-81. PubMed ID: 26839411
[TBL] [Abstract][Full Text] [Related]
46. Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast.
Lada AG; Krick CF; Kozmin SG; Mayorov VI; Karpova TS; Rogozin IB; Pavlov YI
Biochemistry (Mosc); 2011 Jan; 76(1):131-46. PubMed ID: 21568845
[TBL] [Abstract][Full Text] [Related]
47. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
Ito F; Fu Y; Kao SA; Yang H; Chen XS
J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
[TBL] [Abstract][Full Text] [Related]
48. Signatures of mutational processes in human cancer.
Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
[TBL] [Abstract][Full Text] [Related]
49. The APOBEC-2 crystal structure and functional implications for the deaminase AID.
Prochnow C; Bransteitter R; Klein MG; Goodman MF; Chen XS
Nature; 2007 Jan; 445(7126):447-51. PubMed ID: 17187054
[TBL] [Abstract][Full Text] [Related]
50. AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
Svoboda M; Meshcheryakova A; Heinze G; Jaritz M; Pils D; Castillo-Tong DC; Hager G; Thalhammer T; Jensen-Jarolim E; Birner P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Zimmermann P; Zeillinger R; Mechtcheriakova D
BMC Genomics; 2016 Aug; 17(1):643. PubMed ID: 27527602
[TBL] [Abstract][Full Text] [Related]
51. APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.
Glaser AP; Fantini D; Wang Y; Yu Y; Rimar KJ; Podojil JR; Miller SD; Meeks JJ
Oncotarget; 2018 Jan; 9(4):4537-4548. PubMed ID: 29435122
[TBL] [Abstract][Full Text] [Related]
52. Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing.
Sakhtemani R; Senevirathne V; Stewart J; Perera MLW; Pique-Regi R; Lawrence MS; Bhagwat AS
J Biol Chem; 2019 Oct; 294(41):15037-15051. PubMed ID: 31431505
[TBL] [Abstract][Full Text] [Related]
53. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation.
Nabel CS; Jia H; Ye Y; Shen L; Goldschmidt HL; Stivers JT; Zhang Y; Kohli RM
Nat Chem Biol; 2012 Sep; 8(9):751-8. PubMed ID: 22772155
[TBL] [Abstract][Full Text] [Related]
54. APOBEC3A damages the cellular genome during DNA replication.
Green AM; Landry S; Budagyan K; Avgousti DC; Shalhout S; Bhagwat AS; Weitzman MD
Cell Cycle; 2016; 15(7):998-1008. PubMed ID: 26918916
[TBL] [Abstract][Full Text] [Related]
55. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
Nowarski R; Kotler M
Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
[TBL] [Abstract][Full Text] [Related]
56. Genetic modifiers of APOBEC-induced mutagenesis.
Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Bray N; Mitchell D; Lobachev K; Roberts SA
bioRxiv; 2023 Apr; ():. PubMed ID: 37066362
[TBL] [Abstract][Full Text] [Related]
57. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
Krause K; Marcu KB; Greeve J
Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
[TBL] [Abstract][Full Text] [Related]
58. Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.
Orecchini E; Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
Chromosome Res; 2018 Mar; 26(1-2):45-59. PubMed ID: 29396793
[TBL] [Abstract][Full Text] [Related]
59. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
Gao J; Choudhry H; Cao W
Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
[TBL] [Abstract][Full Text] [Related]
60. The mutagenic source and power of our own evolution.
Lindley RA
Adv Genet; 2020; 106():61-73. PubMed ID: 33081927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]